Local induction of lymphangiogenesis with engineered fibrin-binding VEGF-C promotes wound healing by increasing immune cell trafficking and matrix remodeling
Source abstract
Abstract
Lymphangiogenesis occurs in inflammation and wound healing, yet its functional roles in these processes are not fully understood. Consequently, clinically relevant strategies for therapeutic lymphangiogenesis remain underdeveloped, particularly using growth factors. To achieve controlled, local capillary lymphangiogenesis with protein engineering and determine its effects on fluid clearance, leukocyte trafficking, and wound healing, we developed a fibrin-binding variant of vascular endothelial growth factor C (FB-VEGF-C) that is slowly released upon demand from infiltrating cells. Using a novel wound healing model, we show that implanted fibrin containing FB-VEGF-C, but not free VEGF-C, could stimulate local lymphangiogenesis in a dose-dependent manner. Importantly, the effects of FB-VEGF-C were restricted to lymphatic capillaries, with no apparent changes to blood vessels and downstream collecting vessels. Leukocyte intravasation and trafficking to lymph nodes were increased in hyperplastic lymphatics, while fluid clearance was maintained at physiological levels. In diabetic wounds, FB-VEGF-C-induced lymphangiogenesis increased extracellular matrix deposition and granulation tissue thickening, indicators of improved wound healing. Together, these results indicate that FB-VEGF-C is a promising strategy for inducing lymphangiogenesis locally, and that such lymphangiogenesis can promote wound healing by enhancing leukocyte trafficking without affecting downstream lymphatic collecting vessels.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Lymphatic System and Diseases · Body Contouring and Surgery · Sympathectomy and Hyperhidrosis Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (72)
Show source-provided references
1. Control of dendritic cell trafficking in lymphatics by chemokines10.1007/s10456-013-9407-0 ↗
2. Emerging roles of lymphatic endothelium in regulating adaptive immunity10.1172/JCI73316 ↗
3. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development10.1242/dev.122.12.3829 ↗
4. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)10.1073/pnas.95.2.548 ↗
5. Lymphatic function, lymphangiogenesis, and cancer metastasis10.1002/jemt.1160 ↗
6. Myofibroblasts and mechano-regulation of connective tissue remodelling10.1038/nrm809 ↗
7. Biomechanical regulation of blood vessel growth during tissue vascularization10.1038/nm.1985 ↗
8. A new mechanism of blood vessel growth - hope for new treatment strategies
9. Transgenic overexpression of interleukin-1beta induces persistent lymphangiogenesis but not angiogenesis in mouse airways10.1016/j.ajpath.2012.12.003 ↗
10. Biological basis of therapeutic lymphangiogenesis10.1161/CIRCULATIONAHA.107.704098 ↗
11. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing10.1016/S0002-9440(10)65021-3 ↗
12. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis10.1096/fj.06-6656com ↗
13. Characterization of lymphangiogenesis in a model of adult skin regeneration10.1152/ajpheart.00038.2006 ↗
14. Fibroblast alignment under interstitial fluid flow using a novel 3-D tissue culture model10.1152/ajpheart.01008.2002 ↗
15. An in vivo neovascularization assay for screening regulators of angiogenesis and assessing their effects on pre-existing vessels10.1007/s10456-012-9287-8 ↗
16. Neutrophils rapidly transit inflamed lymphatic vessel endothelium via integrin-dependent proteolysis and lipoxin-induced junctional retraction10.1189/jlb.1HI0415-149R ↗
17. Binding of hyaluronan to the native lymphatic vessel endothelial receptor LYVE-1 is critically dependent on receptor clustering and hyaluronan organization10.1074/jbc.M115.708305 ↗
18. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing10.2353/ajpath.2007.060018 ↗
19. Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation10.1038/nm1689 ↗
20. Vascular endothelial growth factor-C accelerates diabetic wound healing10.2353/ajpath.2006.051251 ↗
21. Therapeutic lymphangiogenesis with human recombinant VEGF-C10.1096/fj.02-0401fje ↗
22. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects10.1161/01.CIR.104.1.115 ↗
23. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments10.1098/rsif.2010.0223 ↗
24. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes10.1096/fj.01-1042com ↗
25. Proteolytic processing regulates receptor specificity and activity of VEGF-C10.1093/emboj/16.13.3898 ↗
26. Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function10.1158/0008-5472.CAN-04-0752 ↗
27. Engineering growth factors for regenerative medicine applications10.1016/j.actbio.2015.11.007 ↗
28. Extracellular matrix-inspired growth factor delivery systems for skin wound healing10.1089/wound.2014.0603 ↗
29. Cell-demanded liberation of VEGF-121 from fibrin implants induces local and controlled blood vessel growth10.1161/01.RES.0000126411.29641.08 ↗
30. Fibrin gels and their clinical and bioengineering applications10.1098/rsif.2008.0327 ↗
31. Molecular characterization of lymphatic endothelial cells10.1073/pnas.242401399 ↗
32. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa10.1021/bc9800769 ↗
33. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics10.1073/pnas.0737381100 ↗
34. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro10.1242/jcs.02605 ↗
35. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing10.1126/scitranslmed.3002614 ↗
36. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix10.1073/pnas.1221602110 ↗
37. Engineered aprotinin for improved stability of fibrin biomaterials10.1016/j.biomaterials.2010.08.109 ↗
38. Intravital immunofluorescence for visualizing the microcirculatory and immune microenvironments in the mouse ear dermis10.1371/journal.pone.0057135 ↗
39. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing10.1126/science.1247663 ↗
40. Isolation of murine lymph node stromal cells
41. MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing10.1002/jbm.a.20091 ↗
42. Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism10.1073/pnas.0503681102 ↗
43. Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro10.1016/j.mvr.2004.08.002 ↗
44. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors10.1016/S0002-9440(10)63540-7 ↗
45. Shepro · 2006
46. New insights into intussusceptive angiogenesis
47. Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis10.1007/s10456-013-9365-6 ↗
48. Long-term intravital immunofluorescence imaging of tissue matrix components with epifluorescence and two-photon microscopy
49. Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair10.2353/ajpath.2006.050372 ↗
50. Extracorporeal shock wave therapy combined with vascular endothelial growth factor-C hydrogel for lymphangiogenesis10.1159/000343699 ↗
51. CCR7 and its ligands: balancing immunity and tolerance10.1038/nri2297 ↗
52. CCR7 is involved in the migration of neutrophils to lymph nodes10.1182/blood-2009-11-254490 ↗
53. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype10.1158/0008-5472.CAN-08-1875 ↗
54. Engineered insulin-like growth factor-1 for improved smooth muscle regeneration10.1016/j.biomaterials.2011.09.088 ↗
55. Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin10.1161/01.RES.0000168918.27576.78 ↗
56. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice10.1126/science.276.5317.1423 ↗
57. Chronic lower limb wounds evoke systemic response of the lymphatic (immune) system10.4103/0970-0358.101289 ↗
58. Nonlinear lymphangion pressure-volume relationship minimizes edema10.1152/ajpheart.00239.2009 ↗
59. Mechanics of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation10.1016/S0021-9290(99)00125-6 ↗
60. Interstitial flow as a guide for lymphangiogenesis10.1161/01.RES.0000065621.69843.49 ↗
61. Functionally specialized junctions between endothelial cells of lymphatic vessels10.1084/jem.20062596 ↗
62. Rapid leukocyte migration by integrin-independent flowing and squeezing10.1038/nature06887 ↗
63. Plasticity of button-like junctions in the endothelium of airway lymphatics in development and inflammation10.1016/j.ajpath.2012.02.019 ↗
64. Lymphatic endothelium: morphological, molecular and functional properties10.1083/jcb.200308082 ↗
65. Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds10.1096/fj.04-1592fje ↗
66. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair10.1046/j.1523-1747.2000.00029.x ↗
67. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes10.4049/jimmunol.162.5.2472 ↗
68. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium10.1084/jem.20051759 ↗
69. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications10.1158/0008-5472.CAN-06-1392 ↗
70. Microbiota-dependent sequelae of acute infection compromise tissue-specific immunity10.1016/j.cell.2015.08.030 ↗
71. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation10.1172/JCI200522037 ↗
72. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis10.1038/nm1094 ↗